A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT02574078 · COMPLETED
Trial details
- NCT number
- NCT02574078
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-23
- Primary completion
- 2020-04-15
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.